Literature DB >> 18714569

Differential gene expression analysis of ovarian cancer in a population isolate.

D Grazio1, I Pichler, C Fuchsberger, F Zolezzi, P Guarnieri, H Heidegger, A Scherer, B Engl, S Messini, E Egarter-Vigl, P P Pramstaller.   

Abstract

Gene expression products represent candidate biomarkers with the potential for early screening and therapy of patients with ovarian serous carcinoma. The present study, using patients that originate from the population isolate of South Tyrol, Italy, substantiates the feasibility of differential gene expression analysis in a genetically isolated population for the identification of potential markers of ovarian cancer. Gene expression profiles of fresh-frozen ovarian serous papillary carcinoma samples were analyzed and compared to normal ovarian control tissues using oligonucleotide microarrays complementary to 14,500 human genes. Supervised analysis of gene expression profiling data identified 225 genes that are down-regulated and 635 that are up-regulated in malignant compared to normal ovarian tissues. Class-prediction analysis identified 40 differentially expressed genes for further investigation as potential classifiers for ovarian cancer, including 20 novel candidates. Our findings provide a glimpse into the potential of population isolate genomics in oncological research.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18714569

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  3 in total

1.  Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association Consortium.

Authors:  Ernest K Amankwah; Qinggang Wang; Joellen M Schildkraut; Ya-Yu Tsai; Susan J Ramus; Brooke L Fridley; Jonathan Beesley; Sharon E Johnatty; Penelope M Webb; Georgia Chenevix-Trench; Laura C Dale; Diether Lambrechts; Frederic Amant; Evelyn Despierre; Ignace Vergote; Simon A Gayther; Aleksandra Gentry-Maharaj; Usha Menon; Jenny Chang-Claude; Shan Wang-Gohrke; Hoda Anton-Culver; Argyrios Ziogas; Thilo Dörk; Matthias Dürst; Natalia Antonenkova; Natalia Bogdanova; Robert Brown; James M Flanagan; Stanley B Kaye; James Paul; Ralf Bützow; Heli Nevanlinna; Ian Campbell; Diana M Eccles; Beth Y Karlan; Jenny Gross; Christine Walsh; Paul D P Pharoah; Honglin Song; Susanne Krüger Kjær; Estrid Høgdall; Claus Høgdall; Lene Lundvall; Lotte Nedergaard; Lambertus A L M Kiemeney; Leon F A G Massuger; Anne M van Altena; Sita H H M Vermeulen; Nhu D Le; Angela Brooks-Wilson; Linda S Cook; Catherine M Phelan; Julie M Cunningham; Celine M Vachon; Robert A Vierkant; Edwin S Iversen; Andrew Berchuck; Ellen L Goode; Thomas A Sellers; Linda E Kelemen
Journal:  PLoS One       Date:  2011-05-27       Impact factor: 3.240

2.  Expression of Vascular Endothelial Growth Factor (VEGF) and Epidermal Growth Factor Receptor (EGFR) in Patients With Serous Ovarian Carcinoma and Their Clinical Significance.

Authors:  Reza Ranjbar; Foroogh Nejatollahi; Ahmad Sina Nedaei Ahmadi; Hossein Hafezi; Akbar Safaie
Journal:  Iran J Cancer Prev       Date:  2015-08-24

Review 3.  The Extracellular Matrix in Epithelial Ovarian Cancer - A Piece of a Puzzle.

Authors:  Angela Cho; Viive M Howell; Emily K Colvin
Journal:  Front Oncol       Date:  2015-11-02       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.